SOW
IMMX icon

State of Wyoming’s Immix Biopharma IMMX Stock Holding History

State of Wyoming’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$140K Buy
+13,589
New +$126K 0.01% 1234

Other funds holding IMMX

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IFWM
Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
C
Certuity North Palm Beach, Florida $2.03B AUM 88.59% 1-Year Est. Return

State of Wyoming's IMMX Position: Q2 2026 in Review

State of Wyoming opened a new position in Immix Biopharma (IMMX) in Q2 2026: 13,589 shares worth $140K. The stake represents 0.01% of the portfolio and ranks #1234 among its holdings.

24 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

  • State of Wyoming held 13,589 shares of Immix Biopharma worth $140K as of Q2 2026.
  • Immix Biopharma was a new State of Wyoming position in Q2 2026.
  • Immix Biopharma made up 0.01% of State of Wyoming's portfolio in Q2 2026, its #1234 holding.
  • 24 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.